Information  X 
Enter a valid email address

Dekel Agri-Vision (DKL)

  Print   

Wednesday 10 June, 2020

Dekel Agri-Vision

Appointment of Nomad and Joint Broker

RNS Number : 4593P
Dekel Agri-Vision PLC
10 June 2020
 

 

Dekel Agri-Vision Plc / Index: AIM / Epic: DKL / Sector: Food Producers

 

10 June 2020

 

Dekel Agri-Vision Plc ('Dekel' or the 'Company')

Appointment of Nomad and Joint Broker

 

Dekel Agri-Vision Plc, the West African focused agricultural company, is pleased to advise that it has appointed Arden Partners Plc ("Arden") to act as Nominated Adviser and joint broker with immediate effect.

 

Optiva Securities Limited will remain joint broker alongside Arden.

 

** ENDS **

 

 

For further information please visit the Company's website or contact:

 

DekelOil Public Limited

Youval Rasin

Shai Kol

Lincoln Moore

 

+44 (0) 207 236 1177

Arden Partners Plc (Nomad and Joint Broker)

Paul Shackleton / Ruari McGirr /

Dan Geee-Summons (Corporate Finance)

Simon Johnson (Corporate Broking)

 

+44 (0) 207 614 5900

Optiva Securities Limited (Joint Broker)

Christian Dennis

Jeremy King

 

+44 (0) 203 137 1903

St Brides Partners Ltd (Investor Relations)

Frank Buhagiar

Cosima Akerman

+44 (0) 207 236 1177

 

 

Notes:

 

DekelOil Public Limited is a multi-project, multi-commodity agricultural company focused on West Africa.  It has a portfolio of projects in Côte d'Ivoire at various stages of development: a fully operational palm oil project in Ayenouan where fruit produced by local smallholders is processed at the Company's 70,000tpa crude palm oil mill; a cashew processing project in Tiebissou, which is due to commence production in 2020; and a second palm oil project in Guitry which is under development. 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
APPFLFFARSIAIII

a d v e r t i s e m e n t